ImmuPharma (LON:IMM) Stock Price Up 189.1% – Time to Buy?

by · The Markets Daily

Shares of ImmuPharma plc (LON:IMM – Get Free Report) rose 189.1% during trading on Thursday . The stock traded as high as GBX 3.80 ($0.05) and last traded at GBX 3.47 ($0.04). Approximately 107,693,047 shares were traded during mid-day trading, an increase of 471% from the average daily volume of 18,858,229 shares. The stock had previously closed at GBX 1.20 ($0.01).

ImmuPharma Trading Up 191.7 %

The firm’s fifty day moving average price is GBX 1.36 and its 200 day moving average price is GBX 1.63. The stock has a market capitalization of £14.58 million, a price-to-earnings ratio of -350.00 and a beta of 1.53.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Recommended Stories